Forbes J M & CO LLP Eli Lilly & CO Transaction History

Forbes J M & CO LLP

$960 Million
Q2 2024

A detailed history of Forbes J M & CO LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Forbes J M & CO LLP holds 1,554 shares of LLY stock, worth $1.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,554

Previous 1,568 0.89%

Holding current value

$1.41 Million

Previous $1.22 Million 15.34%

% of portfolio

0.15%

Previous 0.13%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $10,148 - $12,726	-14 Reduced 0.89%	1,554 $1.41 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $14,805 - $19,807	-25 Reduced 1.57%	1,568 $1.22 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $4,348 - $5,107	14 Added 0.89%	1,593 $547,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $10,611 - $12,364	-33 Reduced 2.05%	1,579 $578,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $296,480 - $337,870	-1,000 Reduced 38.28%	1,612 $521,000
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $54,073 - $63,490	-194 Reduced 6.91%	2,612 $847,000
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $3,285 - $4,083	-14 Reduced 0.5%	2,806 $804,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $44,970 - $55,808	200 Added 7.63%	2,820 $779,000
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $53,203 - $64,030	-390 Reduced 12.96%	2,620 $430,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $40,477 - $50,099	340 Added 12.73%	3,010 $419,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $21,384 - $26,486	200 Added 8.1%	2,670 $351,000
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $12,879 - $16,096	-150 Reduced 5.73%	2,470 $265,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $16,388 - $17,578	-200 Reduced 7.09%	2,620 $221,000
Q2 2017 Aug 10, 2017	BUY	N/A	2,820	2,820 $232,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account